
|Videos|August 9, 2022
Unmet Needs and Investigational Therapies in mCSPC
Author(s)Jason Hafron, MD
Dr Jason Hafron concludes his discussion of mCSPC by highlighting the need to work towards a cure for the disease, and two major clinical trials investigating triplet treatment regimens.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5














